UNICHEM LABORATORIES LTD
Latest filings
Next results: Wed, 4 Nov · Financial Results- Board meeting on Nov 4 to consider Q2 and H1 FY27 results · Results
- Quarterly compliance certificate under SEBI Depositories Regulations · Compliance
- USFDA inspection at Goa facility ends with 5 procedural observations · Regulatory & Legal
Snapshot
What the business is, and whether it's a good one at a fair price.
Manufactures and sells pharmaceutical formulations, with 97.6% of standalone turnover coming from exports across 65 countries. Operates 6 manufacturing plants in India across 14 states, four of which are zero liquid discharge facilities, supported by a workforce of 1,907 employees and 908 workers. Formulation volumes rose 131% and standalone revenue grew 84% over the current MD's tenure, reaching Rs 1,475 crore in FY26; on a consolidated basis, total income was Rs 2,201.85 crore with net profit of Rs 252.84 crore. Related party sales accounted for 65.59% of revenue, with material supplies received from a step-down subsidiary. The company's largest cost line is materials at 34.9% of revenue, followed by employees at 18.0% and other operating expenses at 27.3%. EBITDA margin stood at 20.4% in FY26.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
UNICHEMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from UNICHEM LABORATORIES LTD's filed financials and exchange disclosures
What does UNICHEM LABORATORIES LTD do?
UNICHEM LABORATORIES LTD is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol UNICHEMLAB.
Is UNICHEM LABORATORIES LTD profitable?
Yes. Over the trailing twelve months UNICHEM LABORATORIES LTD reported a net profit of ₹305 Cr on revenue of ₹2,308 Cr.
Does UNICHEM LABORATORIES LTD pay a dividend?
Not in the latest reported year — UNICHEM LABORATORIES LTD's dividend payout for FY26 was nil.
Is UNICHEM LABORATORIES LTD debt-free?
No. It reported borrowings of ₹469 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹179 Cr after cash. Debt stands at 0.17× equity. That is higher than 53% of its 166 Pharmaceuticals peers.
Is UNICHEM LABORATORIES LTD expensive compared with its peers?
On trailing P/E, UNICHEM LABORATORIES LTD ranks 24 of 158 in Pharmaceuticals — cheaper than 85% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the UNICHEM LABORATORIES LTD share price move in a day?
On a typical session UNICHEM LABORATORIES LTD moves 1.50% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are UNICHEM LABORATORIES LTD's next results?
Financial Results on Wed, 4 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track UNICHEM LABORATORIES LTD's announcements?
Every NSE and BSE filing by UNICHEM LABORATORIES LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.